Order Article Reprints

Jang H-J, Woo Y-M, Naka K, Park J-H, Han H-J, Kim H-J, Kim S-H, Ahn J-S, Kim T, Kimura S, et al. Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors. Cancers. 2021; 13(21):5543. https://doi.org/10.3390/cancers13215543

Jang, Hyeok-Jae, Young-Min Woo, Kazuhito Naka, Jong-Ho Park, Ho-Jae Han, Hee-Jin Kim, Sun-Hee Kim, Jae-Sook Ahn, Taehyung Kim, Shinya Kimura, and et al. 2021. "Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors" Cancers 13, no. 21: 5543. https://doi.org/10.3390/cancers13215543

Jang, H.-J., Woo, Y.-M., Naka, K., Park, J.-H., Han, H.-J., Kim, H.-J., Kim, S.-H., Ahn, J.-S., Kim, T., Kimura, S., Zarabi, S., Lipton, J. H., Minden, M. D., Jung, C.-W., Kim, H.-J., Kim, J.-W., & Kim, D. D. H. (2021). Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors. Cancers, 13(21), 5543. https://doi.org/10.3390/cancers13215543